Denecimig not checked

Novo Nordisk · NNC0365-3769 · Mim8

FollowEvery change as it happens, and a Monday email
Next date
Phase 3 trial completes
Trials
2 active
7 in total · 2 in the EU
Targets
 

What this is

How it works
An antibody built to latch onto two or more targets at once.-mig: multi-specific immunoglobulins WHO name stem
How it’s given
“Participants in arm 1 will administer Mim8 using an enhanced cartridge and switch to the DV3407 pen-injector once it is approved. Participants in arm 2 and 3 will use the DV3407 pen injector.”In the company’s words, NCT05685238 on ClinicalTrials.gov
Tested for
Haemophilia A (2 trials), Haemophilia A With Inhibitors
Main trialPhase 3
“This study is looking at how Mim8 works in people with haemophilia A, who either have inhibitors or do not have inhibitors. Mim8 is a new medicine that will be used to avoid bleeding episodes. Mim8 works by replacing the function of the missing clotting factor VIII (FVIII). The study will last for up to 5.5 years. The duration of the study depends on when the participant enrolled in this study. The study will end if Mim8 is approved and marketed in participant's country during the study, or the study will end in June 2028, whichever comes first. Participants will get up to 262 injections; the…”In the company’s words, NCT05685238 on ClinicalTrials.gov
Other names
NNC0365-3769 · Mim8

Other drugs for Haemophilia A

All 26 drugs for Haemophilia A

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 30 Jun 2028 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Phase 3Recruiting 23 Mar 2029 A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Phase 3Completed 11 Mar 2024 A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors
Phase 3Completed 18 Jul 2024 A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)
Phase 3Completed 13 Nov 2024 A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors
Phase 2Completed 6 Oct 2023 A Research Study Investigating Mim8 in People With Haemophilia A
Phase 1Completed 13 Oct 2023 A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Denecimig

Following is part of Solo: you see every change to Denecimig the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in